Also trades as: ONCS (NASDAQ) · $vol 1M
ONCSQ OTC
OncoSec Medical Incorporated
1W: +0.0%
1M: +0.0%
3M: +900.0%
YTD: -90.0%
1Y: -90.0%
3Y: -100.0%
5Y: -100.0%
$0.00
+0.00 (+0.00%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Income Trends
Revenue
$0
+0.0% ▲
Gross Profit
-$1M
+1.1% ▲
Operating Income
-$37M
+23.5% ▲
Net Income
-$34M
+24.3% ▲
EPS (Diluted)
$-19.13
+36.7% ▲
EBITDA
-$36M
+21.6% ▲
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 |
|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $0 |
| YoY Growth | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% |
| Cost of Revenue | $0 | $244K | $990K | $1M | $1M |
| Gross Profit | $0 | -$244K | -$990K | -$1M | -$1M |
| Gross Margin | — | — | — | — | — |
| R&D Expenses | $17M | $18M | $25M | $34M | $26M |
| SG&A Expenses | $19M | $12M | $18M | $14M | $11M |
| Operating Expenses | $36M | $30M | $43M | $47M | $36M |
| Operating Income | -$36M | -$30M | -$43M | -$48M | -$37M |
| Operating Margin | — | — | — | — | — |
| Interest Expense | $0 | $4K | $5K | $16K | $21K |
| Income Before Tax | -$39M | -$30M | -$43M | -$48M | -$38M |
| Tax Expense | $680 | $1K | -$873K | -$2M | -$3M |
| Net Income | -$39M | -$30M | -$42M | -$45M | -$34M |
| Net Margin | — | — | — | — | — |
| EPS (Diluted) | $-214.59 | $-94.43 | $-56.22 | $-30.20 | $-19.13 |
| EBITDA | -$32M | -$30M | -$42M | -$46M | -$36M |
| Shares Outstanding | 182378 | 320603 | 751570 | 1M | 2M |